Vergniol, J
Duc, S
Hou, G
Hiriart, J B
Foucher, J
Chenus, F
Fabères, C
Chermak, F
Lafournière, A
Souakri, N
de Lédinghen, V
Article History
Received: 14 May 2015
Accepted: 29 December 2015
First Online: 11 February 2016
Competing interests
: Victor de Lédinghen is a member of the Advisory board of BMS, MSD, Gilead, Janssen and Abbvie. The remaining authors declare no conflict of interest.